The global pharmaceutical contract packaging market is projected to grow from $14.59 billion in 2025 to $30.58 billion by 2034, driven by increased outsourcing, regulatory complexity, and demand for specialized biologics packaging solutions.
- Market projected to reach $30.58 billion by 2034 at a compound annual growth rate of 8.63%, up from $14.59 billion in 2025
- Key growth drivers include pharmaceutical outsourcing, regulatory complexities, cost-effectiveness demands, and the rise of biologics and personalized medicine
- Major market players include West Pharmaceutical Services, Nipro Corporation, CCL Industries, Gerresheimer, and Catalent Pharma Solutions, competing through customized packaging solutions
- Primary challenges include stringent regulatory requirements, high compliance costs, pricing pressures, and volatile raw material and labor costs that impact profit margins
- Growing demand for specialized packaging accommodating complex drug formulations, reduced batch sizes, and stringent storage requirements fuels market expansion
The global pharmaceutical contract packaging market is on a growth trajectory, with multiple industry analyses pointing to a significant expansion over the next decade.
While valuation figures vary by methodology, Fortune Business Insights valued the market at USD 14.59 billion in 2025, projecting it to reach USD 30.58 billion by 2034 at a CAGR of 8.63%. Strategic Packaging Insights places the 2025 market value higher at $22.76 billion, forecasting growth to $40.46 billion by 2034 at a CAGR of 6.60%. Regardless of the exact baseline, both reports confirm this market is expanding fast.
The core of the expansion stems from a shift in how pharmaceutical companies operate. Growing pharmaceutical outsourcing, escalating regulatory complexities, and the need for cost-effectiveness are fueling demand for contract packaging services, Fortune Business Insights says. Additionally, drug manufacturers are seeking flexible, compliant, and scalable packaging solutions to avoid investment in internal infrastructure.
The rise in biologics and personalized medicine is also a driver for market growth. According to Strategic Packaging Insights,these create demand for specialized packaging solutions that accommodate complex drug formulations, reduced batch sizes, and stringent storage and handling requirements.
The market has a semi-consolidated structure, with key players including West Pharmaceutical Services, Nipro Corporation, CCL Industries, Sharp Services, Gerresheimer, and Catalent Pharma Solutions.
These CDMOs maintain their positions through broad service offerings including primary and secondary packaging, blister packaging, and serialization and labeling services. Their ability to offer customized solutions and adhere to stringent regulatory requirements has enabled them to maintain a strong foothold in the market.
However, challenges within the contract packaging market remain. Stringent regulatory requirements and high compliance costs can hinder growth, particularly for smaller operators, while the highly competitive landscape leads to pricing pressures and reduced profit margins. Rising labor costs, energy prices, and volatile raw material costs put further pressure on operating margins.
